| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $189.8M | +45.8% |
| Cost of Revenue | $19.5M | +45.8% |
| R&D Expense | $167.3M | -29.7% |
| SG&A Expense | $194.9M | +35.1% |
| Operating Income | -$192.0M | +27.7% |
| Pre-tax Income | -$196.0M | +24.7% |
| Income Tax | $497K | +43.6% |
| Net Income | -$196.5M | +24.6% |
| EPS (Basic) | -$3.11 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.3M | -39.1% |
| Short-term Investments | $334.6M | +44.6% |
| Accounts Receivable | $26.1M | +40.9% |
| Inventory | $25.8M | +37.4% |
| Current Assets | $466.9M | +24.8% |
| Total Assets | $480.2M | +22.4% |
| Current Liabilities | $105.9M | -8.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.7M | -1.6% |
| Capital Expenditures | $953K | — |
| Investing Cash Flow | -$137.2M | -184.7% |
| Financing Cash Flow | $218.0M | +14.0% |
| Free Cash Flow | -$116.6M | -2.4% |
| +28.3% |
| EPS (Diluted) | -$3.11 | +28.3% |
| Long-term Debt |
| $100.9M |
| -6.8% |
| Total Liabilities | $210.2M | -7.7% |
| Stockholders' Equity | $139.1M | +540.0% |